Henry Kaplan from University of Louisville School of Medicine: Combatting Retinal Degeneration with Glucose

According to Henry Kaplan, MD, University of Louisville School of Medicine, "One has to recognize that there are multiple approaches like gene therapy, neuroprotection, stem cell transplantation, and pharmacologic manipulation of other genes really holds the greatest benefit in terms of trying to reverse the inevitable loss of vision."

At the ARVO 2016 meeting in Seattle, WA, Henry Kaplan, MD, University of Louisville School of Medicine, discussed how access to glucose that would normally be transplanted to the subretinal space for metabolism could aid in restoring normal rod function in retinal degeneration.

"One has to recognize that there are multiple approaches like gene therapy, neuroprotection, stem cell transplantation, and pharmacologic manipulation of other genes really holds the greatest benefit in terms of trying to reverse the inevitable loss of vision," Kaplan commented.